New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For ABT;FB;ALDW;ALJ;LRCX;WES;ABBV;WGP;WHF From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 >>
January 28, 2016
09:26 EDTABTAbbott sees global diagnostics sales up mid single digits for Q1, FY16
Subscribe for More Information
09:19 EDTABT, FBOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Facebook (FB), up 13.9%... Under Armour (UA), up 14.6%... MicroStrategy (MSTR), up 8.9%... Harley-Davidson (HOG), up 8%... Paypal (PYPL), up 6%... Mellanox (MLNX), up 7.9%... Cirrus Logic (CRUS), up 6.2%... Alibaba (BABA), up 4.5%. ALSO HIGHER: Neos Therapeutics (NEOS), up 61.4% after the FDA approved Adzenys XR-ODT for the treatment of ADHD... Exelixis (EXEL), up 4.7% after the U.S. FDA determined the company's New Drug Application for cabozantinib is sufficiently complete... Kinder Morgan (KMI), up 6.7% after being upgraded at Credit Suisse and Stifel. DOWN AFTER EARNINGS: OSI Systems (OSIS), down 21.3%... ServiceNow (NOW), down 22.3%... eBay (EBAY), down 11.5%... InvenSense (INVN), down 10.5%... Juniper Networks (JNPR), down 9.3%... Hologic (HOLX), down 4.4%... Abbott Laboratories (ABT), down 3.6%... Potash (POT), down 2.1%... Qualcomm (QCOM), down 3.6%.
09:19 EDTABTAbbott expects EPS to progressively accelerate throughout 2016
Subscribe for More Information
08:33 EDTFBOptions expected to be active
Subscribe for More Information
08:16 EDTFBFacebook price target raised to $145 from $135 at Jefferies
Subscribe for More Information
08:09 EDTFBFacebook price target raised to $130 from $120 at Stifel
Stifel raised its price target on Facebook after the company reported stronger than expected Q4 results. The firm thinks the company's mobile ad products all performed well, while its user engagement continues to grow steadily. Stifel keeps a Buy rating on the shares.
08:06 EDTWESWestern Gas Partners downgraded at Stifel
As noted earlier, Stifel downgraded Western Gas (WES) to Hold from Buy. he firm thinks that other MLPs have more favorable characteristics than Western Gas, and it believes that Western Gas's cash flows may not be sustained due to its increasing dependence on contributions from Anadarko (APC).
07:50 EDTLRCXLam Research weakness would be a buying opportunity, says Cowen
Subscribe for More Information
07:48 EDTFBFacebook reported solid results, says Oppenheimer
Subscribe for More Information
07:45 EDTFBFacebook price target raised to $140 from $125 at Cowen
Subscribe for More Information
07:35 EDTABTAbbott sees Q1 EPS ex-items 38c-40c, consensus 47c
Subscribe for More Information
07:34 EDTABTAbbott sees FY16 EPS ex-items $2.10-$2.20, consensus $2.26
Subscribe for More Information
07:33 EDTABTAbbott reports Q4 adjusted EPS 62c, consensus 61c
Subscribe for More Information
07:12 EDTABBVAbbVie intiates enrollment in Phase 3 clinical program for Elagolix
AbbVie (ABBV), in cooperation with Neurocrine Biosciences (NBIX), announced the initiation of the first of two planned Phase 3 clinical studies evaluating the safety and efficacy of Elagolix alone or in combination with add-back therapy compared to placebo. These studies are designed to assess the change in menstrual blood loss utilizing the alkaline hematin method, comparing baseline to month six of treatment. Additional secondary efficacy endpoints are being evaluated; including assessing changes in fibroid volume, monthly blood loss and hemoglobin levels. Bone mineral density will also be assessed.
07:00 EDTWESWestern Gas Partners downgraded to Hold from Buy at Stifel
Subscribe for More Information
06:36 EDTFBFacebook price target raised to $145 from $125 at Deutsche Bank
Deutsche Bank analyst Ross Sandler raised his price target for Facebook shares to $145 saying the company's Q4 results delivered the greatest upside since mid-2013. The analyst increased his 2016 revenue and EBITDA estimates by 6.5% and 14.1%, respectively, and keeps a Buy rating on Facebook.
06:18 EDTFBFacebook price target raised to $136 from $127 at JPMorgan
JPMorgan analyst Doug Anmuth raised his price target for Facebook to $136 saying the social media giant is "standing out from the pack" following its Q4 results. Revenue growth is accelerating and margins are expanding, Anmuth tells investors in a post-earnings research note. The company is not seeing signs of macro pressure, he points out. The analyst keeps an Overweight rating on Facebook.
05:54 EDTABBVStocks with implied volatility movement; EMR ABBV
Stocks with implied volatility movement; Emerson (EMR) 38, AbbVie (ABBV) 42 according to iVolatility.
05:46 EDTFBFacebook price target raised to $170 from $155 at Piper Jaffray
Piper Jaffray analyst Gene Munster raised his price target for shares of Facebook (FB) to $170 following the social media giant's Q4 results. The stock is up $11.55, or 12%, to $106.00 in pre-market trading. Facebook beat Q4 revenue estimates by 9% on stronger contribution from core mobile and the ramp of Instagram, Munster tells investors in a post-earnings research note. Management made only one mention of macro concerns for the business in 2016, significantly different than Apple's (AAPL) earnings call on Tuesday night, Munster points out. He expects Facebook shares "can continue to work" and keeps an Overweight rating on the name.
05:37 EDTABBVAbbVie announces venetoclax granted Breakthrough Therapy Designation by FDA
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | 7 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use